Diabetes Research Review Issue 146
In this issue:
Oral orforglipron vs. semaglutide in type 2 diabetes
Tubeless AID vs. MDIs in type 1 diabetes
Associations of GLP-1 agonists and healthy lifestyle with CV outcomes in type 2 diabetes
Cause-specific mortality trends with and without diabetes in high-income settings
Oral semaglutide in early-stage symptomatic Alzheimer disease
Finerenone in type 1 diabetes and CKD
GDM risk increased by daily high temperature exposure
Association of ambient temperature with hypoglycaemia in type 1 diabetes
Contributions of bone microarchitecture to skeletal fragility in longstanding type 1 diabetes
Safety of semaglutide after dialysis initiation
Expert contributor
Professor Mathis Grossmann, MD, PhD, FRACP.
Professor Mathis Grossmann is a physician-scientist trained in both basic biology and in clinical endocrinology/diabetes. He is Professor of Medicine at the Department of Medicine, University of Melbourne, Austin Health, Australia, and a Consultant Endocrinologist at Austin Health. His research focuses on the regulation of cardiometabolic and musculoskeletal health by androgens and oestrogens, at both […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.